Nutrition

Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results – Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health’s Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)

New patent issued for core rare disease target indication for crofelemerJaguar has approximately 200 patents issued and pendingJaguar is supporting...

Near-Infrared (NIR) Spectroscopy Market size is set to grow by USD 698.9 million from 2024-2028, Rising food safety concerns boost the market, Technavio

NEW YORK, July 30, 2024 /PRNewswire/ -- The global near-infrared (NIR) spectroscopy market size is estimated to grow by USD 698.9 million...

error: Content is protected !!